DrugPatentWatch Database Preview

Details for Patent: 9,757,416

« Back to Dashboard

Which drugs does patent 9,757,416 protect, and when does it expire?

Patent 9,757,416 protects AURYXIA and is included in one NDA.

This patent has seventy-eight patent family members in twenty countries.

Summary for Patent: 9,757,416

Title:	Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
Abstract:	The present invention discloses pharmaceutical-grade ferric organic compounds, including ferric citrate, which are soluble over a wider range of pH, and which have a large active surface area. A manufacturing and quality control process for making a pharmaceutical-grade ferric citrate that consistently complies with the established Manufacture Release Specification is also disclosed. The pharmaceutical-grade ferric organic compounds are suitable for treating disorders characterized by elevated serum phosphate levels.
Inventor(s):	Chan; Keith (Rockville, MD), Town; Winston (Hong Kong, CN), Kwok; David W. K. (Vancouver, CA), Stoynov; Nikolay Mintchev (Vancouver, CA)
Assignee:	Panion & BF Biotech Inc. (TW)
Application Number:	14/701,933
Patent Claim Types: see list of patent claims	Use; Composition; Dosage form;

Drugs Protected by US Patent 9,757,416

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Keryx Biopharms	AURYXIA	ferric citrate	TABLET;ORAL	205874-001	Sep 5, 2014		RX	Yes	Yes			Y	Y		CONTROL OF SERUM PHOSPHOROUS LEVELS

International Family Members for US Patent 9,757,416

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2004213819
Australia	2006279333
Australia	2007210090
Australia	2007210096
Canada	2516471
Canada	2619591
Canada	2640763